Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 15, Issue 2, Pages 154-161
Publisher
Springer Science and Business Media LLC
Online
2020-01-28
DOI
10.1038/s41565-019-0619-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle Therapy for Vascular Diseases
- (2019) Alyssa M. Flores et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The clearance of dying cells: table for two
- (2016) D R Green et al. CELL DEATH AND DIFFERENTIATION
- CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
- (2016) Yoko Kojima et al. NATURE
- Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury
- (2016) Simone Alidori et al. Science Translational Medicine
- Carbon Nanotube Degradation in Macrophages: Live Nanoscale Monitoring and Understanding of Biological Pathway
- (2015) Dan Elgrabli et al. ACS Nano
- Phagocytosis of apoptotic cells in homeostasis
- (2015) Sanja Arandjelovic et al. NATURE IMMUNOLOGY
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis
- (2014) Yoko Kojima et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery
- (2014) Bryan Ronain Smith et al. Nature Nanotechnology
- Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice
- (2013) Luisa Campagnolo et al. Particle and Fibre Toxicology
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Shape Matters: Intravital Microscopy Reveals Surprising Geometrical Dependence for Nanoparticles in Tumor Models of Extravasation
- (2012) Bryan Ronain Smith et al. NANO LETTERS
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophages in the Pathogenesis of Atherosclerosis
- (2011) Kathryn J. Moore et al. CELL
- Extramedullary Hematopoiesis Generates Ly-6C high Monocytes That Infiltrate Atherosclerotic Lesions
- (2011) Clinton S. Robbins et al. CIRCULATION
- Imaging Atherosclerotic Plaque Inflammation by Fluorodeoxyglucose With Positron Emission Tomography
- (2010) James H.F. Rudd et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation
- (2010) Valerian E. Kagan et al. Nature Nanotechnology
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- Preparation of carbon nanotube bioconjugates for biomedical applications
- (2009) Zhuang Liu et al. Nature Protocols
- A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice
- (2008) Meike L. Schipper et al. Nature Nanotechnology
- Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy
- (2008) Z. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search